Tutorials › High-Dimensional Genomic Data Analysis › Input Controls and Background in ChIP-seq

Epigenomic and Regulatory Data · Tutorial 782 of 795

Input Controls and Background in ChIP-seq

Learn to choose and scale ChIP-seq controls, compare signal with region-specific background, and recognize when a control does not adequately represent nonspecific signal.

Intermediate 10 min read

What You'll Learn

  • Explain what matched input DNA measures and what it cannot control for
  • Distinguish input, IgG, and no-antibody controls
  • Scale ChIP and control counts for different sequencing depths
  • Interpret enrichment relative to a varying regional background
  • Identify control mismatch, low counts, and other diagnostic warnings
  • Avoid treating normalized ChIP-to-control ratios as proof of specific binding

Why ChIP-seq Needs a Background Reference

A ChIP-seq library contains fragments recovered after an antibody-based enrichment, but not every sequenced fragment represents specific binding of the target. DNA can be recovered through nonspecific interactions with beads, antibody, or other parts of the assay. In addition, genomic regions can differ in how readily they are fragmented, retained, and sequenced. As discussed in the earlier material on ChIP-seq, the observed reads therefore combine biological signal with assay and genomic background.

A control helps characterize some of that background. It does not provide a perfect map of what the ChIP library would look like if the target were absent: its usefulness depends on how it was prepared and which sources of background it shares with the ChIP sample. The central question is consequently not just whether a control was sequenced, but whether it is a reasonable reference for the background relevant to the region being studied.

Definition: A matched input control is DNA from the same biological material as the ChIP sample that is set aside before immunoprecipitation and processed as an unenriched library. It estimates the genomic representation of DNA entering the assay, including some fragmentation and sequencing biases. It does not directly measure antibody-specific or bead-specific nonspecific binding.

A Count Model for Regional Background

Let \(C_r\) be the ChIP read count in genomic region \(r\), and \(I_r\) the matched input count in that region. A simple working model treats counts in the two libraries as independent Poisson variables conditional on their underlying rates:

$$ C_r \sim \operatorname{Poisson}\{s_C(b_r+e_r)\}, \qquad I_r \sim \operatorname{Poisson}(s_I b_r). $$

Here \(s_C\) and \(s_I\) are library-size or exposure factors, \(b_r\) is the region-specific background rate, and \(e_r\) is additional ChIP-associated signal. Under a no-enrichment model for that region, \(e_r=0\). This model is a useful approximation, not a complete description of every library: it assumes that, after scaling, input and ChIP share the relevant background profile. It also assumes Poisson variation, which can be too restrictive when biological or technical variability produces overdispersion.

When library sizes differ, raw counts are not directly comparable. A simple exposure adjustment uses counts per unit of library size:

$$ \text{ChIP rate}_r=\frac{C_r}{s_C}, \qquad \text{input rate}_r=\frac{I_r}{s_I}, \qquad \text{rate ratio}_r= \frac{C_r/s_C}{I_r/s_I}. $$

If the model is appropriate and there is no enrichment, the two scaled rates estimate the same \(b_r\). With enrichment, the ChIP rate estimates \(b_r+e_r\), while input estimates \(b_r\). The rate ratio is therefore a descriptive comparison to background. It is not, by itself, a formal test or a calibrated probability that binding is present. In particular, a ratio based on very small counts can be highly unstable.

Worked Example: Correcting for Different Library Depths

Suppose a hypothetical 1-kilobase region has 240 ChIP reads in a library with 30 million usable reads and 80 input reads in a library with 20 million usable reads. Assume the libraries are otherwise comparable and use total usable reads as the exposure factors, in millions.

The scaled ChIP rate is \(240/30=8\) reads per million, and the scaled input rate is \(80/20=4\) reads per million. Thus the rate ratio is \(8/4=2.00\). Equivalently, \(240\times20/(80\times30)=2.00\).

The observed ChIP rate is twice the input rate in this region. This is evidence of relative enrichment under the stated scaling and background assumptions; it does not establish that the target specifically binds there. The comparison would be less credible if the input came from a different sample or was prepared with substantially different fragmentation.

Why Background Must Be Considered Region by Region

Background is not generally a single constant across the genome. For example, local DNA abundance, copy number, fragment recovery, and sequence-dependent mapping can alter the number of reads observed in a region. Some of these effects can influence both matched libraries; others may differ between them. A region with many ChIP reads may therefore have only modest enrichment if its input count is also high. Conversely, fewer ChIP reads can represent a stronger relative increase over a low local background.

The next example holds library depth and region width fixed to isolate this point. It compares the ratios as descriptive summaries; it does not apply a threshold for deciding which regions are peaks.

Worked Example: High Counts Do Not Necessarily Mean High Enrichment

Consider two hypothetical regions, each 1 kilobase wide. ChIP and input libraries have equal usable depths, so the exposure factors cancel in the rate ratios.

RegionChIP readsInput readsChIP-to-input ratio
A201020/10 = 2.00
B150100150/100 = 1.50

Region B has more ChIP reads than region A, but its input background is also much higher. Its ratio is \(150/100=1.50\), whereas region A's is \(20/10=2.00\). Relative to input, region A shows the larger fold difference in these data. That does not mean its evidence is necessarily more statistically precise: its counts are lower, and sampling variability is consequently more consequential. A sound interpretation considers the background comparison and the amount of information, rather than ranking regions by raw ChIP count alone.

Choosing a Control Strategy

Different controls address different sources of nonspecific signal. They are not interchangeable, and collecting multiple controls does not automatically make the background estimate better. The design should match the suspected source of bias and the practical assay conditions.

Control strategyWhat it can help characterizeImportant limitation
Matched input DNAGenomic representation and some fragmentation or sequencing biases shared with the ChIP materialDoes not reproduce antibody-specific or bead-specific nonspecific recovery
IgG controlRecovery associated with a nonspecific immunoglobulin and the immunoprecipitation procedureMay not behave like the target antibody in binding, concentration, or nonspecific interactions
No-antibody controlRecovery associated with beads and other steps that occur without antibodyDoes not measure nonspecific recovery caused by the antibody itself

A matched input is often a useful reference because it comes from the same biological material and can share important upstream processing. Its interpretation requires that the ChIP and input portions be handled comparably before the point at which they diverge. An IgG control can be informative when nonspecific immunoglobulin-associated recovery is a concern, but it is not a substitute for input: it may differ from the target antibody in properties that affect recovery. A no-antibody control isolates a narrower part of the procedure and likewise cannot stand in for every source of background.

The most defensible choice depends on the assay and scientific question. If a control is not matched to the ChIP sample, differences between libraries may reflect sample composition or handling rather than background alone. Controls should be described by what was actually done, not simply labelled “negative control” as if they represented a universal absence of signal.

Worked Example: Interpreting Conflicting Control Counts

In a hypothetical region, the depth-scaled rates are 6.0 ChIP reads per million, 3.0 input reads per million, 5.0 IgG reads per million, and 1.0 no-antibody reads per million. Assume all four libraries used the same region definition and are technically comparable after scaling.

Relative to input, the ChIP-to-control rate ratio is \(6.0/3.0=2.00\). Relative to IgG, it is \(6.0/5.0=1.20\). Relative to no-antibody, it is \(6.0/1.0=6.00\).

These differing ratios are not contradictory arithmetic. The controls capture different aspects of the procedure: the IgG result suggests substantial recovery associated with nonspecific immunoglobulin or its interaction with the assay, while the no-antibody result does not show the same recovery. The data alone do not determine which control is the appropriate reference for the intended inference. Investigators should report the control design, assess whether it matches the relevant assay steps, and avoid selecting whichever comparison yields the largest ratio.

Justification for Depth Scaling

The purpose of the basic scaling calculation can be seen directly from the count model. If there is no enrichment in region \(r\), then \(e_r=0\), so the expected counts are \(E(C_r)=s_Cb_r\) and \(E(I_r)=s_Ib_r\). Dividing each expectation by its library exposure removes the depth multiplier:

$$ \frac{E(C_r)}{s_C}=b_r=\frac{E(I_r)}{s_I}. $$

Thus equal background rates imply equal expected depth-adjusted counts, even when the raw counts differ because the libraries have different depths. With enrichment, \(E(C_r)/s_C=b_r+e_r\), which exceeds the input rate \(b_r\) when \(e_r>0\). This argument justifies exposure adjustment under the model; it does not show that the model fits the data, nor does it account for uncertainty in estimated ratios.

In practice, library-size factors may need to reflect usable reads and other features of the experiment rather than total reads alone. A single global scaling factor also cannot correct a mismatch in regional background profiles. If control counts are zero or very small, a raw ratio can be undefined or extreme. Adding a pseudocount can make a ratio computable, but the chosen value affects the result and should not be treated as a neutral fix.

Diagnostics, Failure Modes, and Limits

Before interpreting a ChIP-to-control comparison, check that the control is biologically and technically matched, that exposure factors are defined consistently, and that the comparison uses the same genomic region and count rules. Examine whether the control has enough reads in the regions of interest to support a meaningful comparison. Strongly different regional patterns between ChIP and input may signal genuine enrichment, but can also indicate that the shared-background assumption is inadequate.

  • Depth mismatch: If library sizes differ and raw counts are compared directly, an apparently larger ChIP count may simply reflect greater sequencing depth. Scale counts before comparing rates.
  • Control mismatch: An input from another sample, or a control with different processing, may have a different background profile. Matching the label “input” does not eliminate this concern.
  • Low counts: A large ratio from a region with few reads can be unstable. Report the underlying counts alongside the ratio and avoid reading a dramatic fold change as precise evidence.
  • Overdispersion and replicates: Poisson variation assumes the variance equals the mean. If replicate or technical variability is larger, a simple count model understates uncertainty. One control library cannot reveal all such variability.
  • Background not shared: Input does not capture every nonspecific immunoprecipitation effect. Conversely, IgG and no-antibody controls may fail to reproduce other relevant features of the target ChIP.

A control comparison is a way to contextualize observed signal, not a guarantee that all technical biases have been removed. It also cannot, by itself, establish biological function or prove direct binding. The main alternative is to rely on ChIP counts without a control, which avoids potential mismatch between libraries but leaves regional background less directly characterized. Neither approach is universally adequate: the appropriate interpretation depends on assay design, control quality, and the question being asked. Formal peak calling and statistical enrichment decisions require additional procedures beyond the descriptive comparisons developed here.

Common Mistake

Wrong reasoning: “Region B has 150 ChIP reads and region A has 20, so B must have stronger enrichment.” This ignores the fact that B also has 100 input reads, compared with 10 for A. After accounting for the control, the ratios are 1.50 for B and 2.00 for A. The correction is to compare depth-adjusted ChIP and control rates within each region, then consider count size and control suitability before drawing conclusions.

Key takeaway: A control informs the interpretation of ChIP signal only to the extent that it represents relevant background. Match the control to the sample and assay, adjust for library depth, and compare signal with region-specific background rather than ranking regions by raw counts.

Check Your Understanding

Work through these questions, then check each solution.

  1. A ChIP library has 180 reads in a region and 30 million usable reads; its matched input has 60 reads and 15 million usable reads. What is the depth-adjusted rate ratio?
  2. Why might a no-antibody control and an IgG control produce different counts?
  3. Two equal-depth regions have ChIP/input counts of 30/15 and 120/80. Which has the larger descriptive rate ratio, and why is raw ChIP count misleading?
  4. State one assumption behind interpreting a matched input rate as a regional background reference, and one limitation of that assumption.

Solutions. (1) The scaled rates are \(180/30=6\) and \(60/15=4\) reads per million, so the ratio is \(6/4=1.50\). (2) IgG includes nonspecific immunoglobulin-associated recovery, whereas a no-antibody control does not; they therefore characterize different assay components. (3) The first ratio is \(30/15=2.00\), and the second is \(120/80=1.50\). The second region has more raw ChIP reads but also a larger control count, so its relative increase is smaller. (4) The interpretation assumes that, after scaling, input and ChIP share relevant regional background. This can fail if processing differs or if antibody- and bead-associated recovery changes the ChIP background in ways input does not capture.

Clinical Biostats